Thursday, 7 November 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 7 November 2024
Ascott 2
Ascott 2
Latest News
AZ plummets as China investigates

AstraZeneca lost $25.9 billion in market value this week in a fall attributed to an ongoing Chinese investigation which has seen the company's Country President step aside. 

Jobs go in company strategy shift
Another ANZ pharma trims numbers but says impact is minor
TODAY
Biosim leader turns up the heat
Looking to stay on top with a new offering on the cusp of PBS listing
TODAY
AI boom to favour early adopters
Billions being invested seeking shorter time to market
TODAY
Most Popular
Company backs off PBS listing
Leaving rival blockbuster to continue to rule market share
6 November
Aussie pharma's 'lost' drugs
TGA tight-lipped what's happened behind the scenes... for now
6 November
Butler's 'please explain' to PBAC
Access to cancer drugs shaping up as a hot election issue
5 November
There's a new great workplace
Pharma lands first certification, find out where is scored top marks
5 November
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (15)

Access & Reimbursement (1)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (3)

Other (13)

More News
Butler orders extra PBAC meeting
Full meeting to be held next May after industry pushback
6 November
Two years of complete remission
Imugene's immunotherapy yields promising result
6 November
Govt cops fresh flak over PBAC
Accused of a "horrible deception" to create election loophole
6 November
2024's innovation leader unveiled
Announces big company appointment after scooping recognition
6 November
Merck backs homegrown biotech
Emerging Biotech Grant Program expanded to ANZ
5 November
ABC puts heat on bone drug
CHF quick to call for informed consent on the side effects
5 November
Kidney drug hits another hurdle
MSAC defers decision on the company's resubmission
5 November
Local gene tech targets eye market
Discovery could turn $500M market on its head
5 November
Excellence Awards trophies go to...
Two companies tie for the most wins at prestigious Awards night
4 November
GPs enter PBS migraine battle
Rule change hailed a breakthrough in access for three drugs
4 November
15 drugs join TGA's review list
Providing insight into potential new rivalries for 2025
4 November
Who's won a Nov PBS listing?
Small showing for the second-last round of listings for 2025
4 November New to the PBS
Bowen cuts ribbon on solar carpark
Pharma's race to zero emissions by end of 2025
4 November
First copycats of two meds arrive
Targeting a PBS listed drug and another at PBAC this month
4 November Approvals Action
PiF advertise
PiF advertise
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe